USD10
PALI Shares
About Palisade BioPalisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.
USD10
PALI Shares
About Palisade BioPalisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.
Stats
TRADING WINDOW
Closed
OPENS AT
Jul 10 at 1:30 PM GMT+0
MARKET CAP
$338.87M
OPEN PRICE
Not enough data
LOW (1Y)
$0.53
HIGH (1Y)
$2.86
LOW (24H)
$1.90
HIGH (24H)
$2.15
VOLUME (24H)
$2.87M
22.78%
Price history
Time | Price | Change |
|---|---|---|
Today | Not enough data | Not enough data |
1 Day | $2.11 | |
1 Week | $2.03 | |
1 Month | $1.73 | |
1 Year | $0.753 |
Past performance is not a reliable indicator of future results.
Discover more
Popular price predictions
Legal
Information is provided for informational purposes only, and is not investment advice. This is not an invitation, inducement or recommendation to buy any particular asset, or to employ any particular investment strategy. Coinbase makes no representation as to the accuracy, suitability or validity of any information provided.All ticker names are trademarks of their respective holders. Any ticker reference does not imply affiliate with or endorsement by a third-party. Real-time prices are sourced from third parties, but not from all markets. Source: Nasdaq Last Sale. Morningstar data ©2026.